BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20947888)

  • 1. PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.
    Jiang G; Cao F; Ren G; Gao D; Bhakta V; Zhang Y; Cao H; Dong Z; Zang W; Zhang S; Wong HH; Hiley C; Crnogorac-Jurcevic T; Lemoine NR; Wang Y
    Gut; 2010 Nov; 59(11):1535-44. PubMed ID: 20947888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression.
    Xing C; Ye H; Wang W; Sun M; Zhang J; Zhao Z; Jiang G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3920-3928. PubMed ID: 31810373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
    Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.
    Wang F; Hu YL; Feng Y; Guo YB; Liu YF; Mao QS; Xue WJ
    J Surg Oncol; 2019 Jun; 119(8):1108-1121. PubMed ID: 30908656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation.
    Sadanandam A; Sidhu SS; Wullschleger S; Singh S; Varney ML; Yang CS; Ashour AE; Batra SK; Singh RK
    Br J Cancer; 2012 Jul; 107(3):501-7. PubMed ID: 22782341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
    Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
    Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
    Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
    J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
    Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M
    J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
    Abiatari I; Kleeff J; Li J; Felix K; Büchler MW; Friess H
    J Clin Pathol; 2006 Oct; 59(10):1052-8. PubMed ID: 16603650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.
    Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
    Med Oncol; 2010 Sep; 27(3):867-75. PubMed ID: 19763915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
    Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
    Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.
    Hockla A; Miller E; Salameh MA; Copland JA; Radisky DC; Radisky ES
    Mol Cancer Res; 2012 Dec; 10(12):1555-66. PubMed ID: 23258495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway.
    Sun X; Zhang Y; Li B; Yang H
    J Recept Signal Transduct Res; 2018 Aug; 38(4):352-358. PubMed ID: 30396299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
    Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
    Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
    Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
    Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.